Exhibit 32.1
CERTIFICATION PURSUANT TO
SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as President and Chief Executive Officer of Genome Therapeutics Corp. (the “Company”) does hereby certify that to my knowledge:
1) | the Company’s Report on Form 10-Q for the quarter ended September 27, 2003, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
2) | the information contained in the Company’s Report on Form 10-Q for the quarter ended September 27, 2003, fairly presents, in all material respects, the financial condition and results of operations of the Company. |
By: | /s/ Steven M. Rauscher | |
Steven M. Rauscher President & Chief Executive Officer | ||
Dated: November 11, 2003 |